Sequencing Consumables Market - By Product Type (Kits, Reagents, Accessories), Platform (1st, 2nd, 3rd Generation), Application (Clinical Diagnostics [Cancer], Forensic Diagnostics, Pharmacogenomics, Agrigenomics), End-use-& Forecast (2024 - 2032)

Sequencing Consumables Market - By Product Type (Kits, Reagents, Accessories), Platform (1st, 2nd, 3rd Generation), Application (Clinical Diagnostics [Cancer], Forensic Diagnostics, Pharmacogenomics, Agrigenomics), End-use-& Forecast (2024 - 2032)

Sequencing Consumables Market size is poised to record over 22.5% CAGR from 2024-2032, due to increasing adoption in cancer genomics, rare disease diagnosis, and pharmacogenomics for accurate analysis of patient samples. Rising collaboration between sequencing technology providers, consumables manufacturers, and research institutions is driving innovation and development in sequencing consumables. For instance, in October 2022, Illumina inked a new partnership with British-Swedish pharma and biotech company firm AstraZeneca for aligning its AI development efforts with the combination of genomic analysis and drug discovery research. Growing efforts to address unmet needs, develop novel applications, and validate sequencing workflows will also influence the market growth.

The overall industry is segmented into product type, platform, application, end-use, and region.

In terms of platform, the market share from the 3rd generation sequencing consumables segment may record 25.8% CAGR from 2024 to 2032. 3rd generation sequencing platforms generate much longer sequencing reads in comparison to second-generation platforms. To that end, they are particularly useful for resolving complex genomic regions, such as repetitive sequences, structural variations, and epigenetic modifications. Moreover, this technology is increasingly favored for single cell sequencing applications as it allows researchers to analyze the genomes of individual cells with high resolution.

Based on application, the sequencing consumables industry is expected to expand at 22.3% CAGR from the forensic diagnostics segment through 2032. Sequencing consumables, such as DNA extraction kits, PCR reagents, and sequencing libraries have also grown essential for generating DNA profiles from forensic samples. The growing obligation to enable generation, analysis, and interpretation of DNA data for human identification, forensic genomics, medical genetics, and epigenetic analysis in forensic science applications will add to the segment expansion.

Regionally, the Europe sequencing consumables market size is projected to witness over 22% CAGR through 2032, led by the rising clinical sequencing applications, including diagnostic testing. The surge of precision medicine initiatives across the region is driving the demand for sequencing consumables tailored to specific applications, such as targeted sequencing panels and companion diagnostics. Surging advancements in genomics research and the surging adoption of NGS technologies will further shape the regional industry growth.